Unicycive Therapeutics, Inc.
Unicycive Therapeutics, Inc. scores highest on Earnings (63) and lowest on Nitro (20). Its PosiPenta is 39.59 out of 100, weaker than most similar companies.
On the Penta Grid this week, Unicycive Therapeutics, Inc. is Grid #557 of 837 in the Healthcare sector in United States, and Grid #2,924 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Unicycive Therapeutics, Inc. | 39.59 | 31 | 63 | 20 | 51 | 33 |
| vTv Therapeutics Inc. | 53.65 | 36 | 29 | 59 | 78 | 67 |
| Cibus, Inc. | 29.38 | 10 | 50 | 31 | 8 | 48 |
| Seer, Inc. | 53.36 | 46 | 38 | 81 | 56 | 47 |
| LifeMD, Inc. | 30.86 | 5 | 75 | 16 | 15 | 43 |
| OnKure Therapeutics, Inc. | 46.61 | 46 | 40 | 30 | 65 | 53 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.92 |
| P/B ratio | 1.73 |
EEarnings
| Trailing EPS | ₹-165.75 |
| Forward EPS | ₹159.71 |
NNitro
| Price | 318.24 |
| 52-week high | 827.81 |
| 52-week low | 317.30 |
| Fall from 52-week high | 61.6% |
TTorque
| Return on equity (ROE) | -101.07% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 1.82 |
| Market cap | ₹871 Cr |
| Insider holding | 2.26% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Unicycive Therapeutics, Inc.'s PosiPenta score?
Unicycive Therapeutics, Inc.'s PosiPenta is 39.59 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Unicycive Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Unicycive Therapeutics, Inc. is Grid #557 of 837 in the Healthcare sector in United States, and Grid #2,924 of 4,000 in United States.
Which PosiPenta pillar is strongest for Unicycive Therapeutics, Inc.?
Earnings (growth), with a score of 63 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Unicycive Therapeutics, Inc.?
Nitro (momentum), with a score of 20 out of 100: weaker than most similar companies.
Has Unicycive Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.03 points, from 37.56 to 39.59.
PositoAI is for research and education only and is not investment advice.